Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
74.49
+1.23 (1.68%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -66.42 | -115.55 | -135.89 | -62.09 | -13.83 | |
| Depreciation & Amortization | 1.82 | 1.23 | 0.88 | 0.33 | 0.31 | |
| Other Amortization | 0.59 | 0.48 | 0.39 | 0.31 | - | |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.07 | |
| Loss (Gain) From Sale of Investments | -5.48 | -3.62 | -3.42 | -1.05 | 0.59 | |
| Stock-Based Compensation | 41.72 | 27.82 | 19.83 | 13.46 | 8.46 | |
| Other Operating Activities | 0.68 | 2.78 | 0.42 | 0.97 | 6.78 | |
| Change in Accounts Receivable | -38.3 | -30.14 | -16.62 | - | - | |
| Change in Inventory | -1.75 | -2.05 | -3.11 | - | - | |
| Change in Accounts Payable | 6.91 | 2.54 | 4.54 | 0.82 | 3.88 | |
| Change in Other Net Operating Assets | 47.78 | 33.49 | 15.5 | -1.77 | -2.51 | |
| Operating Cash Flow | -12.45 | -83.03 | -117.49 | -49.03 | 3.75 | |
| Capital Expenditures | -9.86 | -1.57 | -1.5 | -0.51 | -0.59 | |
| Sale (Purchase) of Intangibles | - | -5 | -4 | - | - | |
| Investment in Securities | -32.26 | -192.63 | 146.11 | -144.12 | - | |
| Investing Cash Flow | -42.12 | -199.2 | 140.6 | -144.63 | -0.59 | |
| Long-Term Debt Issued | - | 75 | 10 | 20 | - | |
| Net Debt Issued (Repaid) | - | 75 | 10 | 20 | - | |
| Issuance of Common Stock | 143.39 | 105.69 | 120.18 | 74.94 | 0.32 | |
| Other Financing Activities | - | -26.04 | - | -0.95 | -0.3 | |
| Financing Cash Flow | 143.39 | 154.66 | 130.18 | 93.99 | 0.02 | |
| Net Cash Flow | 88.82 | -127.57 | 153.29 | -99.67 | 3.18 | |
| Free Cash Flow | -22.31 | -84.59 | -119 | -49.54 | 3.16 | |
| Free Cash Flow Margin | -4.94% | -46.24% | -682.04% | -191.88% | 5.54% | |
| Free Cash Flow Per Share | -0.53 | -2.25 | -4.05 | -2.01 | 0.15 | |
| Cash Interest Paid | 8.34 | 7.66 | 2.88 | 1.68 | - | |
| Levered Free Cash Flow | -0.16 | -50.48 | -74.49 | -27.35 | 4.74 | |
| Unlevered Free Cash Flow | 4.83 | -46.05 | -72.78 | -26.29 | 4.74 | |
| Change in Working Capital | 14.64 | 3.84 | 0.31 | -0.95 | 1.37 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.